Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects
Clinical trial NCT05173545 · COMPLETED
Trial details
- NCT number
- NCT05173545
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2020-10-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.